These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11835523)

  • 21. Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy.
    Yi B; Hu X; Zhang H; Huang J; Liu J; Hu J; Li W; Huang L
    PLoS One; 2014; 9(6):e99633. PubMed ID: 24936866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.
    Amann B; Tinzmann R; Angelkort B
    Diabetes Care; 2003 Aug; 26(8):2421-5. PubMed ID: 12882873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.
    Titan SM; Vieira JM; Dominguez WV; Moreira SR; Pereira AB; Barros RT; Zatz R
    J Diabetes Complications; 2012; 26(6):546-53. PubMed ID: 22981148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy.
    Tomino Y; Suzuki S; Azushima C; Shou I; Iijima T; Yagame M; Wang LN; Chen HC; Lai KN; Tan SY; Kim MJ
    J Clin Lab Anal; 2001; 15(4):188-92. PubMed ID: 11436201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases.
    Vianna HR; Soares CM; Silveira KD; Elmiro GS; Mendes PM; de Sousa Tavares M; Teixeira MM; Miranda DM; Simões E Silva AC
    Pediatr Nephrol; 2013 Mar; 28(3):463-9. PubMed ID: 23161207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone blockade attenuates urinary monocyte chemoattractant protein-1 and oxidative stress in patients with type 2 diabetes complicated by diabetic nephropathy.
    Takebayashi K; Matsumoto S; Aso Y; Inukai T
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2214-7. PubMed ID: 16569732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.
    Ohlsson S; Bakoush O; Tencer J; Torffvit O; Segelmark M
    Mediators Inflamm; 2009; 2009():584916. PubMed ID: 19587833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of urinary MCP-1 in patients with diabetic nephropathy.
    Saitoh A; Sekizuka K; Hayashi T; Kaneko S; Suzuki Y; Tomino Y
    Nephron; 1998 Sep; 80(1):99. PubMed ID: 9730720
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevated urinary monocyte chemoattractant protein-1 levels in children with Henoch-Schonlein purpura nephritis.
    Wang J; Ying Q; Zhong S; Chen Y; Di Y; Dai X; Zheng J; Shen M
    Pediatr Neonatol; 2018 Jun; 59(3):238-243. PubMed ID: 28919104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
    Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
    Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy.
    Huang F; Horikoshi S; Kurusu A; Shibata T; Suzuki S; Funabiki K; Shirato I; Tomino Y
    J Clin Lab Anal; 2001; 15(1):30-4. PubMed ID: 11170231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy.
    Higurashi M; Ohya Y; Joh K; Muraguchi M; Nishimura M; Terawaki H; Yagui K; Hashimoto N; Saito Y; Yamada K
    J Diabetes Complications; 2009; 23(3):178-84. PubMed ID: 18413205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy.
    Kung WJ; Lin CC; Liu SH; Chaung HC
    Diabetes Technol Ther; 2010 Oct; 12(10):809-13. PubMed ID: 20809684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
    Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
    Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.